Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Lieuwe de Haan, MD, PhD: Reliability and Validity of the Yale-Brown Obsessive-Compulsive Scale in Schizophrenia Patients
1
x
$
30.00
Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis
1
x
$
30.00
Before Attributing Catatonia to Autism with Anxiety, All Other Causes should be Carefully Excluded, Especially in a Patient with Meningioma
1
x
$
30.00
Can We Distinguish Anxiety From Depression?
1
x
$
30.00
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)
1
x
$
0.00
Psychometric Evaluation of a Patient-Rated Troubling Symptom Scale for Generalized Anxiety Disorder Clinical Trials
1
x
$
30.00
The Next Step Forward: A Move Toward Evidence, and Away From Fear of the Industry
1
x
$
0.00
The Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Hospitalized Patients with Acute Schizophrenia: A 6-Week Randomized, Double-Blind, Placebo-Controlled Study
1
x
$
30.00
Development of a Patient-Centered Software System to Facilitate Effective Management of Bipolar Disorder
1
x
$
30.00
C. Lindsay DeVane, PharmD: Risperidone in the Management of Psychiatric and Neurodegenerative Disease in the Elderly: An Update
1
x
$
30.00
The Sex Effects Scale: Pilot Validation in a Healthy Population
1
x
$
30.00
Ripu D. Jindal, MD: Effects of Tranylcypromine on the Sleep of Patients with Anergic Bipolar Depression
1
x
$
30.00
Cara L. Alfaro, PharmD: Emerging Role of Drug Interaction Studies in Drug Development:The Good, the Bad, and the Unknown
1
x
$
30.00
Intravenous Magnesium for the Management of Chronic Pain: An Updated Review of the Literature
1
x
$
30.00
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)
1
x
$
0.00
View Cart
Checkout
Home
Store
“Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
An Update on the Efficacy and Tolerability of Oral Ketamine for Major Depression: A Systematic Review and Meta-Analysis
$
30.00
Add to cart
Details
Efficacy and Tolerability of Lamotrigine in Borderline Personality Disorder: A Systematic Review and Meta-Analysis
$
30.00
Add to cart
Details
Cariprazine to Treat Schizophrenia and Bipolar Disorder in Adults
$
30.00
Add to cart
Details
Asenapine Transdermal Patch for the Management of Schizophrenia
$
30.00
Add to cart
Details
Lumateperone for the Treatment of Schizophrenia
$
30.00
Add to cart
Details
The Use of Prazosin in Treatment of Drug Dreams in Adolescents with Substance Use Disorder: Two Case Reports (OPEN ACCESS)
$
0.00
Add to cart
Details
Patient Response Trajectories in Major Depressive Disorder
$
30.00
Add to cart
Details
Quality of Life Enjoyment and Satisfaction Questionnaire – Short Form (Q-LES-Q-SF)
$
0.00
Add to cart
Details
Pediatric Quality of Life Enjoyment and Satisfaction Questionnaire (PQ-LES-Q)
$
0.00
Add to cart
Details
Quality of Life Enjoyment and Satisfaction Questionnaire (Q-LES-Q)
$
0.00
Add to cart
Details
Use of Clozapine in the General Hospital (OPEN ACCESS)
$
0.00
Add to cart
Details
Naldemedine for the Use of Management of Opioid Induced Constipation
$
30.00
Add to cart
Details
A Comprehensive Update of Lofexidine for the Management of Opioid Withdrawal Symptoms
$
30.00
Add to cart
Details
The Influence of Concentration of Micro-RNA hsa-miR-370-3p and CYP2D6*4 on Equilibrium Concentration of Mirtazapine in Patients With Major Depressive Disorder
$
30.00
Add to cart
Details
Impact of Polymorphism of CYP2D6 on Equilibrium Concentration of Duloxetine in Patients Suffering from Major Depressive Disorder
$
30.00
Add to cart
Details
Assesment of Risk Factors for Tardive Dyskinesia (OPEN ACCESS)
$
0.00
Add to cart
Details
Impact of Recent Methamphetamine Use on Vancomycin Clearance
$
30.00
Add to cart
Details
Autism Spectrum Disorder Screening at 18–36 Months in Infants with Moderate and Severe Neonatal Encephalopathy: Is Routine Screening Required? (OPEN ACCESS)
$
0.00
Add to cart
Details
Antiepileptic Drugs and Bone Health: Current Concepts (OPEN ACCESS)
$
0.00
Add to cart
Details
ASD with the Bor Syndrome: A Case Report (OPEN ACCESS)
$
0.00
Add to cart
Details
Previous
1
…
8
9
10
…
44
Next
Page load link
Go to Top
